DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
January 25 2008 - 9:00AM
PR Newswire (US)
DAVOS, Switzerland, Jan. 25 /PRNewswire-FirstCall/ -- DuPont Senior
Vice President and Chief Science & Technology Officer Uma
Chowdhry offered her perspectives on the importance of science in
the formation of global policy during a discussion at the World
Economic Forum here today. "The role of science is to inform the
policymaking process, to help understand both benefits and risks,
and to inform the limits of what is knowable, and what is
possible," Chowdhry said. "Future progress requires a symbiotic
relationship between science and policy in order to secure a
lasting and sustainable future for ourselves and generations to
come. Policy balances many societal interests. The role of science
in this discourse should be to inform but not fully define that
balance." Chowdhry participated in a forum panel "Science and the
Global Agenda" which considered the relationship between science
and public policy, and outlined how science can inform policymaking
in the future. The discussion addressed aging societies, climate
change, disease eradication, nuclear non- proliferation and
environmental degradation, and the important scientific dimensions
that must be considered. "The magnitude of the challenges that we
are discussing requires major advances in our scientific knowledge
and understanding," Chowdhry said. "Policy makers have the power to
accelerate these advances by setting grand challenges to stimulate
and direct scientific creativity; by providing targeted government
funding to pursue these grand challenges; and, fostering science
education and other programs that build the human scientific
capital to assure the best minds are attracted to these areas.
"Policy also guides science through the establishment of ethical
guidelines and regulatory requirements that specify the conditions
under which new science can be brought to fruition in the
marketplace, Chowdhry noted. "Such regulatory policies are
currently the focus of important debates in emerging areas such as
biotechnologies and nanotechnologies. With nanotechnologies, for
example, there is today a healthy level of interaction of ideas
among policymakers, academic scientists, corporations and public
interest groups that may establish an important model for
constructive collaboration in the future." DuPont is actively
engaged in the global dialogue on nanotechnologies and
biotechnologies. For example, the company has actively called for
and engaged in collaboration in the development of responsible
safety standards and test methods for new nanomaterials as well as
the coordination of research to generate reliable, peer reviewed
data and has called for the adoption of appropriate regulations.
DuPont and Environmental Defense jointly developed, published and
adopted the Nano Risk Framework, available at
http://www.nanoriskframework.org/, which is intended to be used as
a process to identify, manage and reduce potential health, safety
and environmental risks of nanoscale materials across all lifecycle
stages. The company has also testified before the U.S. congress on
the safety, health and environmental implications of new nanoscale
technologies, and is an active participant in the Organization for
Economic Co-operation and Development (OECD) Working Party on
Health and Environmental Safety Implications of Manufactured
Nanomaterials. DuPont also is recognized as a global leader in the
development of new products using biotechnology. The company
practices biotechnology with the same commitment to safety that has
marked more than 200 years of experience in industrial safety. It
complies with regulatory systems in each country where its products
are sold; supports rigorous testing and regulatory safeguards that
carefully consider both human health and environmental protection;
engages a panel of highly regarded outside experts who regularly
review its biotech programs (DuPont external Biotech Advisory
Panel) and uses its Bioethics Guiding Principles for all biotech
projects. For more information, visit
http://www.sustainability.dupont.com/. The World Economic Forum is
an independent international organization committed to improving
the state of the world by engaging leaders in partnerships to shape
global, regional and industry agendas. Incorporated as a foundation
in 1971, and based in Geneva, Switzerland, the World Economic Forum
is impartial and not-for-profit; it is tied to no political,
partisan or national interests. (http://www.weforum.org/). DuPont
Science & Technology provides technologies and transformational
options for new and existing businesses, building on a long, rich
legacy of leading-edge science and innovation. DuPont's focus is on
connecting its unique technology with keen market insight and
foresight to deliver solutions that make peoples lives better,
safer and healthier. In 2007, DuPont commercialized over 1,200 new
products with strong representation from all five growth platforms.
Products commercialized over the last five years accounted for 36
percent of DuPont's total revenue. DuPont is a science-based
products and services company. Founded in 1802, DuPont puts science
to work by creating sustainable solutions essential to a better,
safer, healthier life for people everywhere. Operating in more than
70 countries, DuPont offers a wide range of innovative products and
services for markets including agriculture and food; building and
construction; communications; and transportation. DATASOURCE:
DuPont CONTACT: Michelle Reardon of DuPont, +1-302-774-7447, Web
site: http://www.dupont.com/ http://www.nanoriskframework.org/
http://www.sustainability.dupont.com/ http://www.weforum.org/
Copyright